Christopher M. Jackson

5.8k total citations · 1 hit paper
103 papers, 2.7k citations indexed

About

Christopher M. Jackson is a scholar working on Neurology, Oncology and Genetics. According to data from OpenAlex, Christopher M. Jackson has authored 103 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Neurology, 30 papers in Oncology and 28 papers in Genetics. Recurrent topics in Christopher M. Jackson's work include Glioma Diagnosis and Treatment (28 papers), Cancer Immunotherapy and Biomarkers (20 papers) and Neurosurgical Procedures and Complications (16 papers). Christopher M. Jackson is often cited by papers focused on Glioma Diagnosis and Treatment (28 papers), Cancer Immunotherapy and Biomarkers (20 papers) and Neurosurgical Procedures and Complications (16 papers). Christopher M. Jackson collaborates with scholars based in United States, South Korea and United Kingdom. Christopher M. Jackson's co-authors include Michael Lim, John Choi, Jacob Ruzevick, Charles G. Drake, Henry Brem, Drew M. Pardoll, Jillian Phallen, Zineb Belcaid, Risheng Xu and Dimitrios Mathios and has published in prestigious journals such as SHILAP Revista de lepidopterología, Nature Immunology and PLoS ONE.

In The Last Decade

Christopher M. Jackson

88 papers receiving 2.7k citations

Hit Papers

Mechanisms of immunotherapy resistance: lessons from glio... 2019 2026 2021 2023 2019 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher M. Jackson United States 24 1.2k 1.1k 871 514 431 103 2.7k
Alexander Kroemer United States 23 844 0.7× 901 0.8× 468 0.5× 676 1.3× 316 0.7× 90 3.4k
Gianluigi Zona Italy 28 1.3k 1.1× 688 0.6× 666 0.8× 1.1k 2.2× 250 0.6× 95 3.2k
Matteo Simonelli Italy 27 691 0.6× 262 0.2× 818 0.9× 439 0.9× 823 1.9× 129 2.5k
Sherise D. Ferguson United States 26 441 0.4× 222 0.2× 653 0.7× 519 1.0× 513 1.2× 94 2.0k
J. Bryan Iorgulescu United States 28 458 0.4× 260 0.2× 582 0.7× 522 1.0× 407 0.9× 71 2.4k
Shouwei Li China 23 702 0.6× 378 0.3× 1.0k 1.2× 793 1.5× 423 1.0× 77 2.3k
Marian C. Neidert Switzerland 22 287 0.2× 389 0.3× 599 0.7× 315 0.6× 275 0.6× 108 1.8k
Renato Spaziante Italy 28 1.0k 0.8× 621 0.6× 614 0.7× 668 1.3× 264 0.6× 115 3.2k
Zhao Sun China 29 771 0.6× 354 0.3× 887 1.0× 1.3k 2.5× 350 0.8× 96 2.9k
Jennifer S. Yu United States 24 869 0.7× 241 0.2× 823 0.9× 1.2k 2.3× 826 1.9× 91 2.6k

Countries citing papers authored by Christopher M. Jackson

Since Specialization
Citations

This map shows the geographic impact of Christopher M. Jackson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher M. Jackson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher M. Jackson more than expected).

Fields of papers citing papers by Christopher M. Jackson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher M. Jackson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher M. Jackson. The network helps show where Christopher M. Jackson may publish in the future.

Co-authorship network of co-authors of Christopher M. Jackson

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher M. Jackson. A scholar is included among the top collaborators of Christopher M. Jackson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher M. Jackson. Christopher M. Jackson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jackson, Christopher M., et al.. (2025). Clesrovimab for the Prevention of Respiratory Syncytial Virus Lower Respiratory Tract Disease in Infants. Journal of Pharmacy Technology. 42(2). 98–104.
2.
Kazemi, Foad, Julian Gendreau, Adrian E. Jimenez, et al.. (2025). Creating a predictive model and online calculator for high-value care outcomes following glioblastoma resection: incorporating neighborhood socioeconomic status index. Journal of Neuro-Oncology. 172(2). 407–416. 1 indexed citations
3.
Yedavalli, Vivek, Michael Lim, Christopher M. Jackson, et al.. (2025). Effects of the length of preoperative conservative management on postoperative outcomes after primary microvascular decompression for trigeminal neuralgia. Journal of neurosurgery. 143(1). 92–99.
4.
Xie, Michael E., Christopher M. Jackson, Michael Lim, et al.. (2025). Deep learning–based segmentation of the trigeminal nerve and surrounding vasculature in trigeminal neuralgia. Journal of neurosurgery. 143(1). 83–91.
7.
Hung, Alice, Wuyang Yang, Kathleen R. Ran, et al.. (2025). Liquid Embolic Volume Correlates With Improved Chronic Subdural Hematoma Resolution After Middle Meningeal Artery Embolization. Operative Neurosurgery. 30(1). 36–41. 1 indexed citations
8.
Hansen, Landon J. & Christopher M. Jackson. (2025). The glioma microenvironment and its impact on antitumor immunity. Neuro-Oncology Advances. 7(Supplement_4). iv19–iv31.
9.
Kazemi, Foad, Ali Ahmed, Cathleen C. Kuo, et al.. (2024). Hospital frailty risk score predicts high-value care outcomes following brain metastasis resection. Clinical Neurology and Neurosurgery. 245. 108497–108497. 3 indexed citations
10.
Jimenez, Adrian E., Jiaqi Liu, Foad Kazemi, et al.. (2024). The Hospital Frailty Risk Score Independently Predicts Postoperative Outcomes in Glioblastoma Patients. World Neurosurgery. 183. e747–e760. 3 indexed citations
11.
Feghali, James & Christopher M. Jackson. (2024). Therapeutic implications for the PD-1 axis in cerebrovascular injury. Neurotherapeutics. 22(1). e00459–e00459. 5 indexed citations
12.
13.
Jackson, Christopher M., et al.. (2023). Frailty Predicts Worse Pain Outcomes for Older TN Patients Treated with Microvascular Decompression. World Neurosurgery. 180. e700–e705. 2 indexed citations
14.
Ran, Kathleen R., Jordina Rincón-Torroella, Xiaobu Ye, et al.. (2023). Impact of Antithrombotic Medications and Reversal Strategies on the Surgical Management and Outcomes of Traumatic Acute Subdural Hematoma. World Neurosurgery. 182. e431–e441. 3 indexed citations
15.
Ran, Kathleen R., Justin M. Caplan, Christopher M. Jackson, et al.. (2023). Venous thromboembolism in aneurysmal subarachnoid hemorrhage: Risk factors and timing of chemoprophylaxis. Clinical Neurology and Neurosurgery. 231. 107822–107822. 3 indexed citations
16.
Wu, Adela, Russell Maxwell, Yuanxuan Xia, et al.. (2019). Combination anti-CXCR4 and anti-PD-1 immunotherapy provides survival benefit in glioblastoma through immune cell modulation of tumor microenvironment. Journal of Neuro-Oncology. 143(2). 241–249. 103 indexed citations
17.
Jackson, Christopher M., Christina M. Kochel, Christopher J. Nirschl, et al.. (2015). Systemic Tolerance Mediated by Melanoma Brain Tumors Is Reversible by Radiotherapy and Vaccination. Clinical Cancer Research. 22(5). 1161–1172. 54 indexed citations
18.
Ruzevick, Jacob, Christopher M. Jackson, Jillian Phallen, & Michael Lim. (2012). Clinical Trials with Immunotherapy for High-Grade Glioma. Neurosurgery Clinics of North America. 23(3). 459–470. 14 indexed citations
19.
Ruzevick, Jacob, Christopher M. Jackson, Gustavo Pradilla, Tomás Garzón-Muvdi, & Rafael J. Tamargo. (2012). Aneurysm Formation in Proinflammatory, Transgenic Haptoglobin 2-2 Mice. Neurosurgery. 72(1). 70–76. 19 indexed citations
20.
Jackson, Christopher M., George I. Jallo, & Michael Lim. (2011). Clinical Outcomes after Treatment of Germ Cell Tumors. Neurosurgery Clinics of North America. 22(3). 385–394. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026